Prescription digital therapeutics (PDTs) are evidence-based medical interventions that use software accessed on a tablet or smartphone to prevent, manage, or…
On November 26, 2021, Aimed Alliance sent a letter to U.S. Senators Carper, Coons, Cortez, Masto, Menendez, Murray, Sinema, Schumer and Wyden…
During the COVID-19 pandemic, providers were granted a number of flexibilities and coverage expansions to ensure patients had access to care without…
RealClear Health recently published an article by Peter J. Pitts titled Just How ‘Essential Are Your Health Benefits.’ The article…
On December 16, 2021, the Partnership to Advance Cardiovascular Health (PACH) sent a letter urging CVS Caremark to reverse its…
On December 15, 2021, RealClear Health published Aimed Alliance’s article on non-medical switching titled Improving America’s Mental Health Starts with Consistent Treatment Access The…
On November 30, 2021, the Supreme Court of the United States heard oral arguments from the American Hospital Association (AHA)…
When patients cannot afford their medications, they may receive copay assistance from a pharmaceutical manufacturer or another third-party. Generally, the…
In November 2021, the Smarter Health Care Coalition (SHCC) sent a letter to the Department of the Treasury and the…
On December 9, 2021, ACTION for PDTs’ stakeholder group member, the Center for U.S. Policy (CUSP), presented at the Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC) meeting.…